These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Imaging end points for monitoring neuroprotection in Parkinson's disease. Brooks DJ Ann Neurol; 2003; 53 Suppl 3():S110-8; discussion S118-9. PubMed ID: 12666103 [TBL] [Abstract][Full Text] [Related]
23. [Imaging non motor signs in Parkinson's disease]. Thobois S; Ballanger B; Poisson A; Broussolle E Rev Neurol (Paris); 2012; 168(8-9):576-84. PubMed ID: 22921250 [TBL] [Abstract][Full Text] [Related]
24. Functional imaging in Parkinson's disease. Dagher A Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022 [TBL] [Abstract][Full Text] [Related]
25. [Imaging diagnosis of dementia]. Ishii K Nihon Rinsho; 2014 Apr; 72(4):681-6. PubMed ID: 24796097 [TBL] [Abstract][Full Text] [Related]
26. Functional imaging of non-motor signs in Parkinson's disease. Ballanger B; Poisson A; Broussolle E; Thobois S J Neurol Sci; 2012 Apr; 315(1-2):9-14. PubMed ID: 22154188 [TBL] [Abstract][Full Text] [Related]
27. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease. de Natale ER; Niccolini F; Wilson H; Politis M Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595 [TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of Parkinson's disease]. Arias-Rodríguez M; Morís-De la Tassa G Rev Neurol; 2009 Jan; 48 Suppl 1():S21-5. PubMed ID: 19222011 [TBL] [Abstract][Full Text] [Related]
29. Biomarkers for trials of neuroprotection in Parkinson's disease. Agarwal PA; Stoessl AJ Mov Disord; 2013 Jan; 28(1):71-85. PubMed ID: 22927101 [TBL] [Abstract][Full Text] [Related]
30. Functional imaging studies of non-motoric manifestations of Parkinson's Disease. Stoessl AJ Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S13-6. PubMed ID: 20082973 [TBL] [Abstract][Full Text] [Related]
31. Neuroimaging of depression in Parkinson's disease: a review. Chagas MH; Linares IM; Garcia GJ; Hallak JE; Tumas V; Crippa JA Int Psychogeriatr; 2013 Dec; 25(12):1953-61. PubMed ID: 23992107 [TBL] [Abstract][Full Text] [Related]
32. [Diagnostic use of functional imaging in Parkinson's disease and related disorders]. Hanakawa T; Kawasaki K; Hashikawa K; Fukuyama H Nihon Rinsho; 2004 Sep; 62(9):1733-8. PubMed ID: 15462394 [TBL] [Abstract][Full Text] [Related]
33. The Future of Brain Imaging in Parkinson's Disease. Helmich RC; Vaillancourt DE; Brooks DJ J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163 [TBL] [Abstract][Full Text] [Related]
34. The role of neuroimaging in Parkinson's disease. Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856 [TBL] [Abstract][Full Text] [Related]
35. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. Ceballos-Baumann AO J Neurol; 2003 Feb; 250 Suppl 1():I15-23. PubMed ID: 12761630 [TBL] [Abstract][Full Text] [Related]
36. An update on functional neuroimaging of parkinsonism and dystonia. van Eimeren T; Siebner HR Curr Opin Neurol; 2006 Aug; 19(4):412-9. PubMed ID: 16914982 [TBL] [Abstract][Full Text] [Related]